Author:
Yaylali Emine,Ozdemir Busra,Lacin Neslihan,Ceyil Sumeye
Publisher
Springer International Publishing
Reference48 articles.
1. Alaei A, Alaei K, Waye K, Tracy M, Nalbandyan M, Mutlu E, Cetin MK (2017) Hepatitis C infection and other drug-related harms among inpatients who injected drugs in Turkey. J Viral Hepatitis 24:496–505.
https://doi.org/10.1111/jvh.12662
2. Bağımlılık Yapıcı Maddeler ve Bağımlılık Ile Mücadele 2007 Yılı Ulusal Raporu (2007)
http://www.emcdda.europa.eu/system/files/publications/942/NR2007Tureky_tr.pdf
3. Barut ŞH (n.d.) Hepatit C Viroloji ve Epidemiyoloji.
https://www.klimik.org.tr/wp-content/uploads/2016/01/Hepatit-C-viroloji-ve-epidemiyoloji-Şener-Barut.pdf
4. Bayer College of Medicine (n.d.) Introduction to infectious diseases.
https://www.bcm.edu/departments/molecular-virology-and-microbiology/emerging-infections-and-biodefense/introduction-to-infectious-diseases
. Accessed 10 Mar 2019
5. Van Den Berg CHSB, Smit C, Bakker M, Geskus RB, Berkhout B, Jurriaans S, Coutinho RA, Wolthers KC, Prins M (2007) Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users. Eur J Epidemiol.
https://doi.org/10.1007/s10654-006-9089-7